EUVIMEDEUVIMED entdecken
Crossref

CRISPR-Mediated Epigenetic Reprogramming Attenuates Inflammatory Cell Injury Through Targeted Transcriptional Modulation: An Experimental in Vitro and in Vivo Study

Hiroshi Takamura, Yuki Nakamura, Rina Fujimoto, Keisuke Morita, Ayaka Shimizu, Takeshi Yamamoto

Advanced Journal of Biomedicine & Medicine · 2026

DOI: 10.18081/ajbm.2026.3.294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Journal of Biomedicine & Medicine, 2026. Verfasst von Hiroshi Takamura und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Persistent NF-κB-driven inflammatory transcription promotes inflammasome activation, oxidative stress, mitochondrial dysfunction, and regulated cell death. Although CRISPR-based epigenome editing enables locus-specific transcriptional regulation without permanent modification of the underlying DNA sequence, its capacity to protect against inflammatory cell injury in vivo remains incompletely defined.

Objective

To determine whether dCas9-KRAB-mediated epigenetic repression of Nfkb1 attenuates inflammatory cell injury and to define the molecular mechanisms linking targeted chromatin remodeling with cytoprotection.

Method

A nuclease-inactive CRISPR/dCas9-KRAB system targeting the Nfkb1 regulatory region was evaluated in LPS-stimulated RAW 264.7 macrophages and a murine model of systemic LPS-induced inflammation. Non-targeting sgRNA served as the CRISPR control. Target engagement was assessed by RT-qPCR, immunoblotting, and H3K9me3 ChIP-qPCR. Inflammatory cytokines, NLRP3/caspase-1/GSDMD signaling, intracellular and mitochondrial reactive oxygen species, NRF2-associated antioxidant responses, mitochondrial membrane potential, cell viability, membrane injury, apoptosis, and pyroptosis-associated endpoints were evaluated. In vivo outcomes included circulating cytokines, histopathological injury, neutrophilic infiltration, tissue inflammasome signaling, TUNEL positivity, biochemical indices of organ injury, and survival.

Results

Targeted dCas9-KRAB repression increased H3K9me3 enrichment at the Nfkb1 regulatory locus and reduced Nfkb1 transcription by 64.8% compared with the LPS + non-targeting CRISPR group (P

Zitieren

APA

Takamura, H., Nakamura, Y., Fujimoto, R., Morita, K., Shimizu, A., & Yamamoto, T. (2026). CRISPR-Mediated Epigenetic Reprogramming Attenuates Inflammatory Cell Injury Through Targeted Transcriptional Modulation: An Experimental in Vitro and in Vivo Study. Advanced Journal of Biomedicine & Medicine. https://doi.org/10.18081/ajbm.2026.3.294

Vancouver

Takamura H, Nakamura Y, Fujimoto R, Morita K, Shimizu A, Yamamoto T. CRISPR-Mediated Epigenetic Reprogramming Attenuates Inflammatory Cell Injury Through Targeted Transcriptional Modulation: An Experimental in Vitro and in Vivo Study. Advanced Journal of Biomedicine & Medicine. 2026. doi:10.18081/ajbm.2026.3.294

BibTeX
@article{Takamura2026,
  author = {Takamura, Hiroshi and Nakamura, Yuki and Fujimoto, Rina and Morita, Keisuke and Shimizu, Ayaka and Yamamoto, Takeshi},
  title = {CRISPR-Mediated Epigenetic Reprogramming Attenuates Inflammatory Cell Injury Through Targeted Transcriptional Modulation: An Experimental in Vitro and in Vivo Study},
  journal = {Advanced Journal of Biomedicine & Medicine},
  year = {2026},
  doi = {10.18081/ajbm.2026.3.294}
}
Kostenlos starten →